MTOR and colorectal carcinoma: In addition, downregulated lncRNA RP11‐708H21.4 is related with CRC patients poor prognosis and promotes tumorigenesis through regulation of AKT/mTOR pathway 17, and lncRNA CRNDE promotes CRC cell proliferation and chemoresistance through miR‐181a‐5p‐mediated regulation of Wnt/β‐catenin signaling 18.